D
Biomerica, Inc. BMRA
$0.604 -$0.009-1.47%
Recommendation
Sell
Prev Close
$0.613
Volume
129,246
Avg Vol (90D)
5,697,983
Market Cap
$11.24M
Dividend & Yield
--
52-Week Range
$0.2415 - $1.27
P/E (TTM)
--
EPS (TTM)
-$0.344
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests ...
2/26/2025 - GuruFocus
Biomerica achieves IVDR certification in European union
2/26/2025 - The Fly
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis
2/26/2025 - Globe Newswire
Biomerica announces findings from clinical trial on IBS
2/19/2025 - The Fly
Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
2/19/2025 - Globe Newswire
United Arab Emirates MOHAP approves Biomerica's Fortel PSA Screening Test
1/16/2025 - The Fly
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel PSA Screening Test to Detect an Early Sign of Prostate Cancer
1/16/2025 - Globe Newswire
Biomerica Second Quarter 2025 Earnings: US$0.055 loss per share (vs US$0.09 loss in 2Q 2024)
1/16/2025 - Simply Wall St
Biomerica Reports Second Quarter Fiscal 2025 Financial Results
1/15/2025 - GuruFocus
Biomerica reports Q2 EPS (6c) vs. (9c) last year
1/15/2025 - The Fly
Biomerica Reports Second Quarter Fiscal 2025 Financial Results
1/15/2025 - Globe Newswire
Biomerica (NASDAQ:BMRA) Stock Crosses Above Fifty Day Moving Average - Here's Why
1/7/2025 - Ticker Report
Biomerica secures three key international patents for inFoods Technology
11/21/2024 - The Fly
Biomerica Secures Three Key International Patents for inFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis
11/21/2024 - Globe Newswire
Granahan Investment Management Reduces Stake in Biomerica Inc
11/15/2024 - GuruFocus
Biomerica granted additional 180-day period to meet listing compliance
11/7/2024 - The Fly
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
11/7/2024 - Globe Newswire
Biomerica announces direct-to-consumer availability of inFoods IBS test
10/30/2024 - The Fly
Biomerica Announces Direct-to-Consumer Availability of inFoods IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
10/30/2024 - Globe Newswire
Biomerica First Quarter 2025 Earnings: US$0.078 loss per share (vs US$0.067 loss in 1Q 2024)
10/17/2024 - Simply Wall St
Biomerica reports Q1 results
10/16/2024 - SeekingAlpha.com: All News
Biomerica reports Q1 EPS (8c) vs. (7c) last year
10/16/2024 - TipRanks Financial Blog
Biomerica reports Q1 EPS (8c) vs. (7c) last year
10/16/2024 - The Fly
Biomerica Reports First Quarter Fiscal 2025 Financial Results
10/16/2024 - Globe Newswire
Biomerica (NASDAQ:BMRA) Shares Cross Below Two Hundred Day Moving Average - Should You Sell?
10/5/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$5.58M
EBITDA (TTM)
-$5.80M
EBIT (TTM)
-$5.89M
Net Income (TTM)
-$5.61M
Balance Sheet
Total Assets (Q)
$7.27M
Total Debt (Q)
$626.00K
Total Liabilities (Q)
$2.16M
Book Value Per Share (Q)
$0.2789
Cash Flow
Cash from Operations (TTM)
-$4.98M
Cash from Investing (TTM)
-$73.00K
Cash from Financing (TTM)
$299.00K
Net Change in Cash (TTM)
-$4.76M
Filings
Filing Date
Tuesday, January 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Apr 7 and 11 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
-15.20%
30-Day Total Return
-11.58%
60-Day Total Return
115.71%
90-Day Total Return
94.21%
Year to Date Total Return
99.34%
1-Year Total Return
-40.78%
2-Year Total Return
-74.62%
3-Year Total Return
-83.18%
5-Year Total Return
-76.22%
52-week Low
Aug 05, 2024 - $0.2415
52-week High
Jan 16, 2025 - $1.27
Valuation
Market Cap
$11.24M - Nano Cap
Enterprise Value
$9.49M
Price/Sales (TTM)
1.88
Price/Book (Q)
2.20
Dividends and Shares
Shares Outstanding
17.12M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biomerica.com
Phone Number
(949) 645-2111
Address
17571 Von Karman Avenue
Irvine, CA 92614
Country
United States
Year Founded
1971
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical... more
NASDAQ 03/12/2025 4:00PM Eastern Quotes delayed
Weiss Ratings